MTSS1 and acute myeloid leukemia: Taken together, our findings suggest not only that MTSS1 expression is increased in AML subsets with a more favorable outcome but its expression and potential function can be increased by pharmacological approaches allowing for the investigation of future potential alternative therapies, although more in depth genetic and pharmacological studies are required to carefully dissect the exact function of this adapter and tumor suppressor molecule.